Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Cert. of designation
Director departure
SKYSTAR BIO-PHARMACEUTICAL CO (SKBI) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/28/2016 8-K/A Quarterly results
04/06/2016 8-K Form 8-K - Current report
10/30/2013 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
10/26/2012 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
07/06/2012 8-K Form 8-K - Current report
04/27/2012 8-K Form 8-K - Current report
01/19/2012 8-K Form 8-K - Current report
11/15/2011 8-K Form 8-K - Current report
08/23/2011 8-K Form 8-K - Current report
08/04/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement between registrant and Bing Mei",
"Grayling Christopher Chu 284-9426 [email protected]"
05/24/2011 8-K Form 8-K - Current report
01/04/2011 8-K Form 8-K - Current report
12/17/2010 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter from Frazer Frost, LLP to the U.S. Securities and Exchange Commission",
"Grayling"
11/16/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Skystar Bio-Pharmaceutical Announces Record Organic Revenues of $18.5 Million For Third Quarter Fiscal Year 2010 - Company reiterates fiscal 2010 guidance of $45.5 Million to $47.5 Million - XI’AN, CHINA – November 16, 2010 -- - Skystar Bio-Pharmaceutical Company , a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today reported unaudited third quarter fiscal year 2010 earnings, for the period ended September 30, 2010."
09/07/2010 8-K Form 8-K - Current report
09/01/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Grayling"
08/17/2010 8-K Form 8-K - Current report
05/18/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidance Increased to $45.5 Million to $47.5 Million XI’AN, CHINA – May 18, 2010 -- - Skystar Bio-Pharmaceutical Company , a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today reported unaudited first quarter fiscal year 2010 earnings, for the period ended March 31, 2010. First Quarter 2009 Highlights"
05/12/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Grayling Christopher Chu, Director 284-9426 [email protected]"
04/19/2010 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Employment Agreement",
"Services Agreement",
"Restricted Stock Award Agreement",
"Grayling"
03/17/2010 8-K Investor presentation
Docs: "Presentation of Skystar Bio-Pharmaceutical Company"
03/08/2010 8-K Form 8-K - Current report
03/02/2010 8-K Form 8-K - Current report
01/07/2010 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter from MSWFT"
12/22/2009 8-K Form 8-K - Current report
12/16/2009 8-K Other Events, Financial Statements and Exhibits
12/09/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and Provides Operational Update on Facility Development"
11/20/2009 8-K Form 8-K - Current report
11/17/2009 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
Docs: "Certificate of Change Pursuant to NRS 78.209 with an effective date of November 16, 2009"
11/16/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "Skystar Bio-Pharmaceutical Company Announces Third Quarter 2009 Financial Results"
11/12/2009 8-K Investor presentation
Docs: "# # #"
11/05/2009 8-K Other Events, Financial Statements and Exhibits
09/09/2009 8-K Form 8-K - Current report
09/09/2009 8-K Investor presentation
Docs: "Presentation of Skystar Bio-Pharmaceutical Company"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy